ABSTRACT
We aimed to evaluate the safety and efficacy of a transobturator sling [TOT] procedure by using an adjustable TOT device in the treatment of stress urinary incontinence [SUI]. The data of 89 patients who had the diagnosis of SUI and underwent TOT operation by using an adjustable MUS device of SAFYRE t plus [Promedon] between June 2005 - November 2012, were retrospectively evaluated. The pateints were evaluted by the parametres of physical examination, stress test, ultrasonography, uroflowmetry, residual urine measurement, cystometry, subjective incontinence scoring [VASi], patients' satisfaction scoring [VASs], and ICQ-SF questionnaire. The preoperative, perioperative, and postoperative collected data were statistically analysed to determine the efficacy and safety of TOT application by using SAFYRE t plus. The mean age, account of parity, and body mass index was 55.3 +/- 10.1, 2.34 +/- 1.43, and 24.97 +/- 3.7, respectively. While the pre- and postoperative results of stress test, VASi, and ICIQ-SF scores were significantly different [P=0.00 in all], the pre- and postoperative results of Qmax and PVR account were similar [P= 0.84, P= 0.79, respectively]. The severity of subjective incontinence [VASi score] significantly improved after the operation. The mean VASs score at postoperative 12[th] month was 7.75 +/- 1.11. The subjective and objective cure rates were%89.9 [80/89] and%78.6 [70/89], respectively. The TOT operation by using SAFYRE t plus, which was an adjustable sling device, seemed to be an efficient, reasonably safe, minimally invasive treatment alternative for the surgical management SUI in women